1. A Crossover Study of Risperidone in Children, Adolescents and Adults with Mental Retardation.
- Author
-
Hellings, Jessica, Zarcone, Jennifer, Reese, R. Matthew, Valdovinos, Maria G., Marquis, Janet G., Fleming, Kandace K., and Schroeder, Stephen R.
- Subjects
RISPERIDONE ,INTELLECTUAL disabilities ,DRUG efficacy ,AUTISM ,AFFECTIVE disorders ,GENDER ,CHILDREN with intellectual disabilities ,BEHAVIOR ,PEOPLE with intellectual disabilities ,THERAPEUTICS - Abstract
Risperidone has shown safety and efficacy for aggressive and destructive behaviors in short-term studies. This longer-duration study includes a broad sample. Forty subjects, aged 8โ56 years (mean=22), all with mental retardation and 36 with autism spectrum disorders participated in this 22-week crossover study, with 24 weeks of open maintenance thereafter. Of 40 subjects, 23 (57.5%) responded fully (50% decrease in Aberrant Behavior Checklist-Community Irritability subscale score), while 35 subjects (87.5%) showed a 25% decrease. Gender, mood disorder, and antiseizure medications did not alter response. Increased appetite and weight gain were common. Low dose risperidone was effective for aggressive behavior in persons with MR. More long-term studies are needed, incorporating weight control interventions. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF